Tyr-D-Ala-Gly-Phe-Leu sequence mimics met-enkephalin. Binds δ-opioid receptors in nerve terminals, activating G-protein pathway that reduces neurotransmitter vesicle release. Complementary but distinct from SNARE-targeting peptides — acts upstream at neural signaling level.
Studies have administered: Topical 5% in research formulations; often combined with argireline
Combination with argireline (10%) vs argireline alone: greater wrinkle depth reduction. Mechanism synergy via two distinct pathways confirmed in vitro. Clinical trial data shows up to 24% wrinkle reduction in combination protocol.
Well-tolerated topically; opioid receptor activity via topical route unlikely to produce systemic effects at cosmetic concentrations
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Leuphasyl — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat